AAAAAA

   
Results: 1-25 | 26-46
Results: 1-25/46

Authors: LOOMISPRICE LD COX JH MASCOLA JR VANCOTT TC MICHAEL NL FOUTS TR REDFIELD RR ROBB ML WAHREN B SHEPPARD HW BIRX DL
Citation: Ld. Loomisprice et al., CORRELATION BETWEEN HUMORAL RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUSTYPE-1 ENVELOPE AND DISEASE PROGRESSION IN EARLY-STAGE INFECTION, The Journal of infectious diseases, 178(5), 1998, pp. 1306-1316

Authors: SITZ KV LOOMISPRICE LD KIM SR KENNER JR SAU P ECKELS KH REDFIELD RR BIRX DL
Citation: Kv. Sitz et al., DELAYED-TYPE HYPERSENSITIVITY SKIN TESTING USING V3 LOOP PEPTIDES IDENTIFIES T-LYMPHOCYTE EPITOPES IN HIV-INFECTED INDIVIDUALS, Journal of allergy and clinical immunology, 99(1), 1997, pp. 208-208

Authors: SITZ KV LOOMISPRICE LD RATTOKIM S KENNER JR SAU P ECKELS KH REDFIELD RR BIRX DL
Citation: Kv. Sitz et al., DELAYED-TYPE HYPERSENSITIVITY SKIN TESTING USING 3RD VARIABLE LOOP PEPTIDES IDENTIFIES T-LYMPHOCYTE EPITOPES IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS, The Journal of infectious diseases, 176(4), 1997, pp. 1085-1089

Authors: LOWELL GH KAMINSKI RW VANCOTT TC SLIKE B KERSEY K ZAWOZNIK E LOOMISPRICE L SMITH G REDFIELD RR AMSELEM S BIRX DL
Citation: Gh. Lowell et al., PROTEOSOMES, EMULSOMES, AND CHOLERA-TOXIN-B IMPROVE NASAL IMMUNOGENICITY OF HUMAN-IMMUNODEFICIENCY-VIRUS GP160 IN MICE - INDUCTION OF SERUM, INTESTINAL, VAGINAL, AND LUNG IGA AND IGG, The Journal of infectious diseases, 175(2), 1997, pp. 292-301

Authors: KIM JH LOVELAND JE SITZ KV KIM SR MCLINDEN RJ TENCER K DAVIS K BURKE DS BOSWELL RN REDFIELD RR BIRX DL
Citation: Jh. Kim et al., EXPANSION OF RESTRICTED CELLULAR IMMUNE-RESPONSES TO HIV-1 ENVELOPE BY VACCINATION - IL-7 AND IL-12 DIFFERENTIALLY AUGMENT CELLULAR PROLIFERATIVE RESPONSES TO HIV-1, Clinical and experimental immunology, 108(2), 1997, pp. 243-250

Authors: KIM JH MCLINDEN RJ MOSCA JD BURKE DS BOSWELL RN BIRX DL REDFIELD RR
Citation: Jh. Kim et al., TRANSCRIPTIONAL EFFECTS OF SUPERINFECTION IN HIV CHRONICALLY INFECTEDT-CELLS - STUDIES IN DUALLY INFECTED CLONES, Journal of acquired immune deficiency syndromes and human retrovirology, 12(4), 1996, pp. 329-342

Authors: KIM JH MCLINDEN RJ MOSCA JD VAHEY MT GREENE WC REDFIELD RR
Citation: Jh. Kim et al., INHIBITION OF HIV REPLICATION BY SENSE AND ANTISENSE REV RESPONSE ELEMENTS IN HIV-BASED RETROVIRAL VECTORS, Journal of acquired immune deficiency syndromes and human retrovirology, 12(4), 1996, pp. 343-351

Authors: RATTO S SITZ KV SCHERER AM LOOMIS LD COX JH REDFIELD RR BIRX DL
Citation: S. Ratto et al., CD4(-LYMPHOCYTE LINES DEVELOPED FROM HIV-1-SEROPOSITIVE PATIENTS RECOGNIZE DIFFERENT EPITOPES WITHIN THE V3 LOOP() T), Journal of acquired immune deficiency syndromes and human retrovirology, 11(2), 1996, pp. 128-136

Authors: MICHAEL NL DAVIS KE LOOMISPRICE LD VANCOTT TC BURKE DS REDFIELD RR BIRX DL
Citation: Nl. Michael et al., V3 SEROREACTIVITY AND SEQUENCE VARIATION - TRACKING THE EMERGENCE OF V3 GENOTYPIC VARIATION IN HIV-1-INFECTED PATIENTS, AIDS, 10(2), 1996, pp. 121-129

Authors: LOOMIS LD DEAL CD KERSEY KS BURKE DS REDFIELD RR BIRX DL
Citation: Ld. Loomis et al., HUMORAL RESPONSES TO LINEAR EPITOPES ON THE HIV-1 ENVELOPE IN SEROPOSITIVE VOLUNTEERS AFTER VACCINE THERAPY WITH RGP160, Journal of acquired immune deficiency syndromes and human retrovirology, 10(1), 1995, pp. 13-26

Authors: ALLEN PJ GILLESPIE DL REDFIELD RR GOMEZ ER
Citation: Pj. Allen et al., LOWER-EXTREMITY LYMPHEDEMA CAUSED BY ACQUIRED IMMUNE-DEFICIENCY SYNDROME-RELATED KAPOSIS-SARCOMA - CASE-REPORT AND REVIEW OF THE LITERATURE, Journal of vascular surgery, 22(2), 1995, pp. 178-181

Authors: KIM JH SITZ KV RATTO S MCLINDEN RJ DAVIS K BURKE DS BOSWELL RN MOSCA JD REDFIELD RR BIRX DL
Citation: Jh. Kim et al., ANTIGEN-INDUCIBLE EXPRESSION OF AN EXOGENOUS IL-7 GENE IN HUMAN, ANTIGEN-SPECIFIC T-CELLS, Journal of cellular biochemistry, 1995, pp. 396-396

Authors: SITZ KV RATTO S SCHERER AM LOOMIS L REDFIELD RR BOSWELL RN BURKE DS BIRX DL
Citation: Kv. Sitz et al., GP120 PEPTIDE RECOGNITION BY PBMCS FROM HIV-INFECTED PATIENTS IMMUNIZED WITH EITHER, Journal of cellular biochemistry, 1995, pp. 314-314

Authors: MICHAEL NL MO T MERZOUKI A OSHAUGHNESSY M OSTER C BURKE DS REDFIELD RR BIRX DL CASSOL SA
Citation: Nl. Michael et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CELLULAR RNA LOAD AND SPLICING PATTERNS PREDICT DISEASE PROGRESSION IN A LONGITUDINALLY STUDIED COHORT, Journal of virology, 69(3), 1995, pp. 1868-1877

Authors: RATTO S SITZ KV SCHERER AM MANCA F LOOMIS LD COX JH REDFIELD RR BIRX DL
Citation: S. Ratto et al., ESTABLISHMENT AND CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ENVELOPE-SPECIFIC CD4(-LYMPHOCYTE LINES FROM HIV-1-SEROPOSITIVE PATIENTS() T), The Journal of infectious diseases, 171(6), 1995, pp. 1420-1430

Authors: VANCOTT TC BETHKE FR BURKE DS REDFIELD RR BIRX DL
Citation: Tc. Vancott et al., LACK OF INDUCTION OF ANTIBODIES SPECIFIC FOR CONSERVED, DISCONTINUOUSEPITOPES OF HIV-1 ENVELOPE GLYCOPROTEIN BY CANDIDATE AIDS VACCINES, The Journal of immunology, 155(8), 1995, pp. 4100-4110

Authors: KIM JH RATTO S SITZ KV MOSCA JD MCLINDEN RJ TENCER KL VAHEY MT STLOUIS D BIRX DL REDFIELD RR
Citation: Jh. Kim et al., CONSEQUENCES OF STABLE TRANSDUCTION AND ANTIGEN-INDUCIBLE EXPRESSION OF THE HUMAN INTERLEUKIN-7 GENE ON TETANUS-TOXOID-SPECIFIC T-CELLS, Human gene therapy, 5(12), 1994, pp. 1457-1466

Authors: VANCOTT TC BETHKE FR KALYANARAMAN V BURKE DS REDFIELD RR BIRX DL
Citation: Tc. Vancott et al., PREFERENTIAL ANTIBODY RECOGNITION OF STRUCTURALLY DISTINCT HIV-1 GP120 MOLECULES, Journal of acquired immune deficiency syndromes, 7(11), 1994, pp. 1103-1115

Authors: BISELLI R LOOMIS LD DELBONO V BURKE DS REDFIELD RR BIRX DL
Citation: R. Biselli et al., IMMUNIZATION OF HIV-INFECTED PATIENTS WITH RGP160 - MODULATION OF ANTI-RGP120 ANTIBODY SPECTROTYPE, Journal of acquired immune deficiency syndromes, 7(10), 1994, pp. 1016-1024

Authors: VAHEY M BIRX DL MICHEAL NL BURKE DS REDFIELD RR
Citation: M. Vahey et al., ASSESSMENT OF GAG DNA AND GENOMIC RNA IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS IN HIV-INFECTED PATIENTS RECEIVING INTERVENTION WITH A RECOMBINANT GP160 SUBUNIT VACCINE IN A PHASE-I STUDY, AIDS research and human retroviruses, 10(6), 1994, pp. 649-654

Authors: BURNETT PR POLONIS V VANCOTT TC BIRX DL REDFIELD RR
Citation: Pr. Burnett et al., IMMUNOGLOBULIN A-MEDIATED NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, AIDS research and human retroviruses, 10, 1994, pp. 190000034-190000034

Authors: REDFIELD RR BIRX DL BRUNDAGE J ARONSON N JOHNSON S KIM J LENNOX J MICHAEL N ROBB M SITZ K OSTER C BURKE DS
Citation: Rr. Redfield et al., LONG-TERM CLINICAL FOLLOW-UP OF VOLUNTEERS ENROLLED IN AN RGP160 PHASE-1 SAFETY AND IMMUNOGENICITY VACCINE THERAPY TRIAL, AIDS research and human retroviruses, 10, 1994, pp. 190000157-190000157

Authors: SITZ KV VANCOTT TC DARDEN JM REDFIELD RR BIRX DL
Citation: Kv. Sitz et al., NAIVE AND MEMORY T-LYMPHOCYTES IN THE CONTEXT OF A PHASE-I GP160 VACCINE THERAPY TRIAL, AIDS research and human retroviruses, 10, 1994, pp. 190000159-190000159

Authors: REDFIELD RR
Citation: Rr. Redfield, IMMUNE BASED STRATEGIES FOR THE TREATMENT AND PREVENTION OF HIV-INFECTION AND DISEASE, AIDS research and human retroviruses, 10, 1994, pp. 190000033-190000033

Authors: RATTO S SITZ KV LOOMIS LD MANCA F REDFIELD RR BIRX DL
Citation: S. Ratto et al., EPITOPE MAPPING OF CD4(-LYMPHOCYTE LINES FROM SEROPOSITIVE PATIENTS ENROLLED IN A GP160 VACCINE TRIAL() T), Journal of cellular biochemistry, 1994, pp. 293-293
Risultati: 1-25 | 26-46